Figure S2 from Xevinapant plus Chemoradiotherapy Negatively Sculpts the Tumor-Immune Microenvironment in Head and Neck Cancer

<p>In vivo studies of xevinapant in combination with RT or CRT in the mEER model.</p>

Zapisane w:

Opis bibliograficzny
1. autor:	Charleen Chan Wah Hak (22698167) (author)
Kolejni autorzy:	Emmanuel C. Patin (22698170) (author), Anton Patrikeev (22698173) (author), Annalisa Nicastri (22698176) (author), Zuza Kozik (22698179) (author), Holly Baldock (22698182) (author), Joan N. Kyula-Currie (15016394) (author), Victoria Roulstone (20823102) (author), Amarin Wongariyapak (22698185) (author), Valentina Gifford (22698188) (author), Tencho Tenev (22698191) (author), Elizabeth S. Appleton (22698194) (author), Lisa C. Hubbard (22698197) (author), Shane Foo (22698200) (author), Malin Pedersen (22698203) (author), Jyoti S. Choudhary (17408556) (author), Masahiro Ono (22698206) (author), Alan A. Melcher (20823117) (author), Antonio Rullan (14941920) (author), Kevin J. Harrington (17801531) (author)
Wydane:	2025
Hasła przedmiotowe:	Cancer Tumor Biology Therapeutic Research and Development Immuno-oncology Methods and Technology Animal Models Of Cancer Head, Neck & Oral Cancers Immunology Immunomodulation Preclinical Models Radiation Oncology Combined modality therapies Tumor Microenvironment
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy